Open Science Framework
Daratumumabe na Trombocitopenia Imune: Uma Revisão de Escopo
By Daniel dos Santos Rocha.
Abstract
Esta revisão de escopo mapeia as evidências científicas sobre o uso do anticorpo monoclonal anti-CD38 (Daratumumab) no manejo da Trombocitopenia Imune (PTI). Analisa a eficácia clínica, esquemas posológicos, perfil de segurança e a recuperação da contagem plaquetária por meio da depleção de plasmócitos autorreativos.
Keywords
- Platelet Disorders and Treatments
- daratumumab
- idiopathic thrombocytopenic purpura
- anti-CD38 monoclonal antibody
- platelet recovery
- drug safety
- dosing regimen
- clinical efficacy
- Open access
Source
Published in Open Science Framework. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.